Keith Cooper, MD
Family Medicine · Conway, ARNPI 1295732816
Payments from drug & device makers
Across 149 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$331
- Abbott$326
- Novo Nordisk$281
- Pfizer$198
- Merck$160
- Lilly USA, LLC$144
- plus $929 from 21 others
What the payments were for
- Food & beverage$2,32798%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $331 |
| Abbott | 17 | $326 |
| Novo Nordisk | 28 | $281 |
| Pfizer | 10 | $198 |
| Merck | 10 | $160 |
| Lilly USA, LLC | 10 | $144 |
| Novartis | 7 | $135 |
| Amgen | 7 | $125 |
| Amarin Pharma, Inc. | 7 | $118 |
| Medline Industries LP | 1 | $99 |
| AstraZeneca | 5 | $79 |
| Boston Scientific | 3 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Antares Pharma, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
| Bayer | 1 | $12 |
| Sumitomo Pharma America, Inc. | 1 | $10 |
How this compares
$2,370 in reported general payments places this provider in the 75th percentile of 1,347 family medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 39 | $42,253 |
| TrulicityDulaglutide | 23 | $26,063 |
| OzempicSemaglutide | 17 | $22,499 |
| XareltoRivaroxaban | 19 | $19,964 |
| Spiriva RespimatTiotropium Bromide | 14 | $7,440 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $5,183 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,678 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,743 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 71 | $1,534 |
| Omeprazole | 76 | $1,445 |
| Testosterone | 17 | $1,433 |
| Rosuvastatin Calcium | 78 | $1,314 |
| Atorvastatin Calcium | 136 | $1,067 |
| Duloxetine Hcl | 32 | $990 |
| Levothyroxine Sodium | 121 | $973 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $15 | $49,69253 claims |
| Lilly USA, LLCTrulicity | $144 | $26,06323 claims |
| Novo NordiskOzempic | $281 | $22,49917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Conway
- Landon HumphreyConway$417K
- Thad HardinConway$19K
- David NaylorConway$17K
- Lander SmithConway$16K
- Randal BowlinConway$16K
- Joe CumminsConway$15K
- John DicksonConway$15K
- Michael CarsonConway$14K
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.